−4.76 MUSD
95.33 KUSD
368.41 M
About Amarantus Bioscience Holdings, Inc.
Sector
Industry
CEO
Donald D. Huffman
Headquarters
New York
Founded
2008
ISIN
US02300U2050
FIGI
BBG000BDC4B4
Amarantus BioScience Holdings, Inc. is a biopharmaceutical company, which engages in developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. It focuses on acquiring product and technology rights, raising capital, and performing research and development. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in New York, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AMBS is 0.000100 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Amarantus Bioscience Holdings, Inc. stocks are traded under the ticker AMBS.
Amarantus Bioscience Holdings, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
AMBS stock is 0% volatile and has beta coefficient of 3.47. Check out the list of the most volatile stocks — is Amarantus Bioscience Holdings, Inc. there?
Yes, you can track Amarantus Bioscience Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
AMBS stock hasn't changed in a week, the month change is a 50.00% fall, over the last year Amarantus Bioscience Holdings, Inc. has showed a 90.00% decrease.
No, AMBS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AMBS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Amarantus Bioscience Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Amarantus Bioscience Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Amarantus Bioscience Holdings, Inc. stock shows the sell signal. See more of Amarantus Bioscience Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.